I was initially tempted to write briefly about a robotics-focused closed-end fund with the clever ticker BOT where the CEO purchased $10 million worth of stock as part of a secondary offering, but the insider purchases at health insurance company Elevance Health (ELV) turned out to be more interesting.
With the Elevance purchases coming in on Friday afte…